Susquehanna International Group, LLP Ocugen, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Ocugen, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,060,841 shares of OCGN stock, worth $753,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,060,841

Previous 943,037 12.49%

Holding current value

$753,197

Previous $754,000 0.13%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.52 - $0.9 $61,258 - $106,023	117,804 Added 12.49%	1,060,841 $753,000
Q4 2024 Feb 14, 2025	BUY	$0.72 - $1.08 $52,035 - $78,052	72,271 Added 8.3%	943,037 $754,000
Q3 2024 Nov 14, 2024	BUY	$0.98 - $1.95 $225,420 - $448,540	230,021 Added 35.9%	870,766 $862,000
Q2 2024 Aug 15, 2024	SELL	$1.18 - $1.98 $656,497 - $1.1 Million	-556,354 Reduced 46.48%	640,745 $993,000
Q1 2024 May 07, 2024	BUY	$0.5 - $1.83 $425,754 - $1.56 Million	851,508 Added 246.39%	1,197,099 $1.96 Million
Q4 2023 Feb 14, 2024	SELL	$0.36 - $0.57 $28,515 - $45,149	-79,210 Reduced 18.65%	345,591 $196,000
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $248,880 - $385,764	-622,200 Reduced 59.43%	424,801 $169,000
Q2 2023 Aug 11, 2023	SELL	$0.45 - $0.88 $618,267 - $1.21 Million	-1,373,928 Reduced 56.75%	1,047,001 $565,000
Q1 2023 May 16, 2023	BUY	$0.82 - $1.33 $1.63 Million - $2.64 Million	1,982,473 Added 452.15%	2,420,929 $2.06 Million
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $858,671 - $1.45 Million	-773,578 Reduced 63.82%	438,456 $569,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $436,621 - $773,443	249,498 Added 25.92%	1,212,034 $2.16 Million
Q2 2022 Aug 15, 2022	SELL	$1.83 - $3.45 $1.39 Million - $2.63 Million	-760,935 Reduced 44.15%	962,536 $2.19 Million
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $1.35 Million - $2.71 Million	574,805 Added 50.04%	1,723,471 $5.69 Million
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $1.95 Million - $6.99 Million	-446,014 Reduced 27.97%	1,148,666 $5.23 Million
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $1.74 Million - $2.33 Million	274,228 Added 20.77%	1,594,680 $11.5 Million
Q2 2021 Aug 11, 2021	SELL	$5.52 - $15.68 $137,961 - $391,890	-24,993 Reduced 1.86%	1,320,452 $10.6 Million
Q1 2021 May 17, 2021	BUY	$1.66 - $15.81 $2.23 Million - $21.3 Million	1,345,445 New	1,345,445 $9.14 Million
Q4 2020 Feb 16, 2021	SELL	$0.28 - $2.6 $6,168 - $57,283	-22,032 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.2 - $0.72 $4,406 - $15,863	22,032 New	22,032 $7,000
Q2 2020 Aug 14, 2020	SELL	$0.22 - $0.46 $33,131 - $69,274	-150,597 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.26 - $0.73 $39,155 - $109,935	150,597 New	150,597 $42,000

Others Institutions Holding OCGN

# of Institutions

115

Shares Held

74.9M

Call Options Held

200K

Put Options Held

151K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $154M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Ocugen, Inc. Transaction History